Amgen ends collaboration agreement with Kyowa Kirin for eczema asset
Source: SeekingAlpha
2026-01-30 14:46:01 ET
More on Amgen
- Amgen: A Buy In 2026 On Exciting MariTide Obesity - T2D Potential
- 44th Annual J.P. Morgan Healthcare Conference
- Amgen Inc. (AMGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- TrumpRx launch now delayed - report
- Notable analyst calls this week: Amgen, Chevron and Procter & Gamble among top picks
Read the full article on Seeking Alpha
For further details see:
Amgen ends collaboration agreement with Kyowa Kirin for eczema asset
Kyowa Hakko Kogyo
NASDAQ: KYKOF
KYKOF Trading
-13.15% G/L:
$12.42 Last:
100 Volume:
$12.42 Open:
